Month: September 2024

Grant will enable ONWARD Medical, CEA-Clinatec and .NeuroRestore to evaluate the use of the ONWARD ARC-BCI™ System to restore thought-driven movement of the hands and arms after spinal cord injury (SCI) EINDHOVEN, the Netherlands, Sept. 03, 2024 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a grant from the Christopher & Dana Reeve Foundation to support expansion of an ongoing early clinical feasibility study to explore the use of a brain-computer interface (BCI) to restore thought-driven use of the hands and arms after SCI. The ongoing early feasibility clinical study is also supported by the European Innovation Council...

TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) — BHP Xplor, the six-month accelerator program aimed at revolutionizing critical mineral exploration, has officially opened applications for the 2025 cohort. Following the success of the 2023 and 2024 cohorts, BHP Xplor is excited to invite early-stage explorers to join its next chapter. Once again, the program is seeking visionary teams focused on uncovering new sources of critical minerals crucial for a sustainable future. The BHP Xplor program is designed to accelerate participants’ exploration opportunities while fostering long-term relationships with BHP. Participants will benefit from up to $500K equity-free funding, expert mentorship, and invaluable connections within BHP’s extensive network of suppliers and service providers. Since inception BHP has entered partnerships with...

Tommy MAUSSIN – CARBIOS Chief Marketing OfficerTommy Maussin joins CARBIOS as Chief Marketing Officer and member of its Executive CommitteeClermont-Ferrand (France), 3 September 2024 (06:45 CET). CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announces the appointment of Tommy Maussin as its Chief Marketing Officer, effective 2 September 2024.  His mission involves developing and overseeing CARBIOS’ global marketing and sales activities with brands across various industries, including packaging, textiles, luxury, automotive, cosmetics, healthcare, and industrial goods. Tommy will be responsible for enhancing CARBIOS’ global presence to initiate and conclude commercial agreements with brand owners....

The New Portal streamlines management, offering scalable security services at the click of a button BANGKOK, Sept. 02, 2024 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading cyber security platform provider of AI-powered, cloud delivered solutions, today unveiled its innovative Portal designed for both managed security service providers (MSSPs) and distributors. This platform significantly simplifies service delivery and enhances the ease of doing business with Check Point. According to Canalys, the global MSSP market is projected to grow by 14.2% annually, driven by increasing cyber threats and the need for specialized security services. However, MSSPs and channel partners today face a range of challenges—from efficiently scaling their services, managing multiple customers across disparate security...

SAN CARLOS, Calif., Sept. 02, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it will hold a webcast and conference call tomorrow, September 3, 2024, at 8:00 a.m. Eastern Time to present topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX-31, the Company’s 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), in healthy adults aged 50 and older. To participate in the conference call, please dial 800-225-9448 (domestic) or 203-518-9708 (international) and refer to conference ID PCVX0903. A live webcast of the conference call will also be available on the investor...

MONTREAL, Sept. 02, 2024 (GLOBE NEWSWIRE) — Velan Inc. (TSX: VLN) (“Velan” or the “Company”), a world-leading manufacturer of industrial valves, announced today that it has entered into a Main Services Agreement (“MSA”) with GEH SMR Technologies Canada Ltd. (“GEH”) to provide certain products and services that may be required by GEH for the provision of a stand-alone Small Modular Reactor (“SMR”) to Ontario Power Generation Inc. Under the terms of the MSA, GEH has placed an initial purchase order with the Company to develop technology and products related thereto. Anticipated future purchase orders for similar SMR’s in Canada, the United States and around the world, the receipt of which are dependent on the Company’s continued ability to develop and deliver required products and services under the MSA, could have a material impact...

BOSTON, Mass., Sept. 02, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will share the topline results from the Phase 2 EMBOLD study of relutrigine (PRAX-562) in SCN2A and SCN8A Developmental and Epileptic Encephalopathies (DEEs) on Tuesday, September 3, 2024, prior to market open. Following the announcement, the Company will host a conference call and webcast presentation at 8:00 a.m. ET to discuss the trial results. Conference Call and Webcast PresentationDate and Time: Tuesday, September 3, 2024 at 8:00 a.m. ETWebcast: LINK A replay of the presentation will be posted, when...

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024 U.S. commercial launch, expected at the beginning of 2025, fully funded with over €85 million in new capital raisedNyxoah – NASDAQ Closing Bell Ceremony 29 août 2024 Mont-Saint-Guibert, Belgium – September 2, 2024 10:05pm CET / 4:05PM ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), rang the Nasdaq Closing Bell on August 29, 2024 to recognize the Company’s recent progress and highlight upcoming milestones on its path to the U.S. market launch of...

EDF estimates higher nuclear power generation in France for 2024 Thanks to the good industrial performance of France’s nuclear fleet, EDF revises higher its estimate nuclear power generation in France for 2024. Initially estimated between 315-345TWh, nuclear power generation is now estimated between 340-360TWh1. This higher nuclear power generation estimate is based on improved performance of outages and industrial control of stress corrosion inspections and repair work, and the absence of major climatic event during summer. The Group has implemented the START2 2025 action plan aimed at improving the operational efficiency of outages, since 2019. It covers various areas: industrialisation, capitalisation, and standardisation of outages preparation methods, a refined strategy for allocating resources and skills, including the setting...